FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Vaccines | Rheumatoid Arthritis

Trial set for rheumatoid arthritis cure

A team of scientists at Newcastle University is preparing a small human trial to test a one-shot approach to curing rheumatoid arthritis with a vaccine devised from a patient's white blood cells. The cells are taken from the volunteers and manipulated with a recipe of chemicals, steroids and Vitamin D so they can suppress the immune system rather than spur it. And a single jab could be enough to suppress the auto-immune response that triggers rheumatoid arthritis. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Vaccines   Rheumatoid Arthritis